Top Stocks
Top Analyst Stocks
Top Smart Score Stocks
Top Insiders Stocks
Popular
Stock Screener
Top Online Growth Stocks
Trending Stocks
Penny Stock Screener
Dividend Investing
Dividend Calculator
Dividend Yield Calculator
Dividend Stocks
Dividend News
Dividend Calendar
ETFs
ETF Center
SPY ETF
QQQ ETF
Stock Comparison
ChatGPT Stocks
Value Stocks
Airline Stocks
AI Stocks
Oil Stocks
Bank Stocks
FAANG Stocks
Compare More Stocks…
Calendars
IPO Calendar
Earnings Calendar
Popular
Dividend Calendar
Economic Calendar
New
Market Holidays
Daily Analyst Ratings
Daily Insider Trading
Research Tools
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Stock Market News
Stock Analysis & Ideas
Popular
ETF News
Global Markets News
Expert Spotlight
TipRanks Labs
Earnings Reports Insights
Market Breakdowns
Dividend Stock News
Crypto News
News
My Portfolio
My Performance
My Portfolio Analysis
Crowd Insights
My Watchlist
Smart Portfolio
About Us
About TipRanks
Contact Us
Working with TipRanks
Enterprise Solutions
Tools for Trading Platforms
Data for Hedge Funds
Best Online Brokers
Become an Affiliate
Follow Us
More
Plans
News
Smart Portfolio
Expert Center
Ideas
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
ETF Center
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed Tools
Try Now
Top Stocks
Smart Score Stocks
Analysts' Hot Stocks
Insiders' Hot Stocks
Popular
Trending Stocks
Fastest Growing Websites
Hot
Penny Stocks
Market Movers
Top Experts
My Experts
Top Firms
Top Wall Street Analysts
Top Financial Bloggers
Top Corporate Insiders
Popular
Top Hedge Fund Managers
Top Individual Investors
Research Tools
Stock Screener
Stock Comparison
Dividend Calculator
Popular
ETF Center
Dividend Yield Calculator
Daily Stock Ratings
Daily Insider Transactions
Comparisons
Stock Comparison
POPULAR COMPARISONS
Dividend Stocks
ChatGPT Stocks
Airline Stocks
AI Stocks
Smart Portfolio
My Portfolio
My Performance
My Portfolio Analysis
Crowd Insights
Calendars
Earnings Calendar
Popular
Dividend Calendar
Economic Calendar
New
IPO Calendar
Stock Market Holidays
News
Market News
ETF News
Stock Analysis & Ideas
Popular
Global Markets News
Expert Spotlight
Tipranks Labs
Earnings Reports Insights
Market Breakdowns
Dividend Stock News
Crypto News
About Us
About TipRanks
For Business
Become an Affiliate
Reviews
Contact Us
Plans & Pricing
ABVC
Stock Latest News
The Fly
ABVC BioPharma’s Maitake Mushroom Dietary Supplement approved in Taiwan
7d ago
ABVC
The Fly
ABVC BioPharma provides 2023 pipeline update
20d ago
ABVC
Press Releases
ABVC BioPharma Provides 2023 Pipeline Update
20d ago
ABVC
Press Releases
ABVC BioPharma Receives $3.175 Million Investment From The Lind Partners to Continue Clinical Trials
25d ago
ABVC
The Fly
ABVC receives Australian TGA approval to initiate Phase II study of vitargus
27d ago
ABVC
The Fly
ABVC BioPharma presents ABV-1505 ADHD Phase IIa results
2M ago
ABVC
Press Releases
ABVC BioPharma ABV-1505 ADHD Phase IIa Results Presented at 2023 APSARD Conference
2M ago
ABVC
The Fly
ABVC announces FDA approved IND submission for study of ABV-1519
2M ago
ABVC
Press Releases
FDA Approves IND Submission Allowing ABVC BioPharma to Proceed With Clinical Study of ABV-1519 for Treatment of Non-Small Cell Lung Cancer
2M ago
ABVC
Press Releases
ABVC BioPharma Provides Vitargus® Update – Phase II Vitargus® Study Protocol Received Thai FDA Approval
4M ago
ABVC
Press Releases
ABVC BioPharma Reports Third Quarter 2022 Financial and Operational Results
4M ago
ABVC
The Fly
ABVC BioPharma receives notice of allowance of patent for ABV-1504
4M ago
ABVC
Press Releases
ABVC BioPharma Receives Notice of Allowance from US Patent and Trademark Office for ABV-1504 Used to Treat Major Depressive Disorder (MDD)
4M ago
ABVC
Press Releases
Cedars-Sinai Medical Center Joins Phase I Clinical Study of ABVC BioPharma’s Medication for Treating Depression in Cancer Patients
5M ago
ABVC
Press Releases
ABVC BioPharma Announces Vitargus® Phase II Study Plan Approved by HREC in Australia
6M ago
ABVC
Market News
ABVC BioPharma (NASDAQ:ABVC) in Focus on ADHD Trial Update
6M ago
ABVC
Press Releases
ABVC BioPharma Provides ADHD Phase II Part 2 Clinical Study Update and Announces UCSF Institutional Review Board Approval
6M ago
ABVC
Press Releases
ABVC Biopharma Announces Letter to Shareholders
6M ago
ABVC
Press Releases
ABVC BioPharma Selects Additional Vitargus® Phase II Study Site
6M ago
ABVC
Press Releases
ABVC Provides Oncology Pipeline Updates
7M ago
ABVC
Press Releases
ABVC BioPharma Provides Vitargus® Update
7M ago
ABVC
Press Releases
ABVC BioPharma Reports Second Quarter 2022 Financial and Operational Results
7M ago
ABVC
Press Releases
ABVC Notes New Report That Estimates Global Retinal Surgical Instruments Market to Grow to $2.46 Billion by 2028
8M ago
ABVC
Press Releases
ABVC BioPharma Submitted Vitargus® Phase II Study Plan to Australia HREC
9M ago
ABVC
Press Releases
ABVC BioPharma Announces Termination of Two Contracts
9M ago
ABVC
Press Releases
ABVC BioPharma Engaged by Orion BioTech to Identify Global Licensing Partners
10M ago
ABVC
You need to enable JavaScript to run this app.